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LETTER TO THE EDITOR
Neurofibromatosis and childhood leukaemia
Sir - We read with interest the article on the increased risk
for childhood leukaemias in neurofibromatosis (Stiller et al.,
1994). This study confirmed the results of the first
population-based study on the incidence of various malig-
nant disorders in neurofibromatosis type 1 (NF-1) (Matsui et
al., 1993). The importance ofpopulation-based studies of rare
diseases cannot be overemphasised.
For many years it was suspected that children with NF-i
and cutaneous juvenile xanthogranuloma (JXG) may have a
greater risk of juvenile chronic myelogenous leukaemia
(JCML) (Morier et al., 1990). Recently, we analysed the
data gathered from all published cases with various
associations between NF-1, JXG and JCML (Zvulunov et
al., 1995). We estimated that the relative risk for JCML in
children with NF-I and JXG is 20- to 32-fold greater than in
children with NF-I that do not have JXG. We estimated that
among children with NF-I and JXG the frequency of JCML
is between 1/52 and 1/84, which is 1700- to 5500-fold higher
than in a general population (Grier, 1987).
In their description of the patients with myeloid
leukaemias Stiller et al. (1994) reveal that case 4 was
previously reported by Shaw and Eden (1989). The unusual
feature in this case was the presentation of JCML with
hyphema. Careful reading of this case history reveals that the
patient had 'three small skin nodules, on her trunk and scalp
and that hyphema developed after 'conjunctivitis' without
circumstantial evidence of trauma. There was no evidence of
bleeding diathesis. Although the authors did not provide a
diagnosis for the skin nodules, they apparently entertained a
diagnosis of 'cutaneous xanthomata' in their discussion. We
strongly suspect that the cutaneous lesions were JXGs and
that the cause of the hyphema was an undiagnosed ocular
JXG. Common causes of spontaneous hyphema include
localised tumours, such as JXG or retinoblastoma, and
blood dyscrasias with bleeding diathesis. The presenting
clinical signs of ocular JXG are one or more of the
following: (1) an asymptomatic localised tumour of the iris;
(2) heterochromia of the iris; (3) unilateral glaucoma; (4)
spontaneous hyphema; and (5) red eye with signs of uveitis
(Nicholson and Green, 1983). Among children with ocular
JXG 'one or more lesions are present elsewhere on the body
in the majority of patients in whom they have been sought'
(Nicholson and Green, 1983). Our belief that patient 4 of
Stiller et al. (1994) has had ocular and cutaneous JXGs is
based on the presence of three of the above-mentioned
presenting signs and symptoms, the absence of bleeding
tendency at the time of diagnosis of hyphema and the
presence of cutaneous lesions consistent with JXG.
The inclusion of a patient with JXG in assessment of a
relative risk of JCML in NF-I may have caused an increase
of the calculated risk for patients without JXG. Never-
theless, the increased risk for JCML in children with NF-I is
now well established. Paediatricians should particularly look
for signs and symptoms of JCML in male infants with NF-I
and JXG in whom the risk for the disease may be as high as
2%.
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